<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230807059068N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-14</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Comapring the effectiveness of establishing continuous positive airway pressure through RAM cannula with nasal mask and nasal prong in newborns</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the effectiveness of establishing continuous positive airway pressure through RAM cannula with nasal mask and nasal prong in newborns admitted to neonatal intensive care unit</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71916</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: 90 infants participating in the study will be subjected to continuous positive airway pressure treatment with RAM cannula (30 people), nasal mask (30 people) and nasal prongs (30 people) in three groups using block randomization method. Six are used. All blocks are the same size. Within each block of 6, two people are randomly assigned to group A, two people to group B, and two people to group C. 15 blocks of 6 are used for this study.
The software used for block allocation is R software. Blockrand Package is used in this software. Randomization of six permutation blocks, all possible blocks are arranged as follows
Block 1: ABCABC, Block 2: AABBCC, Block 3: ABCCBA, Block 4: CCBBAA, Block 5: CBACBA, Block 6: CBAABC
To select 90 people, we randomly select 15 blocks from numbers 1 to 6. Using R software, we choose a random number between 1 and 6. For example, if number 6 is selected as the sixth block and number 2 is selected as the second block, the people entering the study will be given CBAABCAABBCC respectively. Finally, group A received the intervention of short nose cannula, group B received the nasal mask intervention, and group C received the RAM cannula intervention through connection to the system.
After study completion, intervention data for each group can be added to the data frame for analysis. Each intervention is written on a card and the cards are sealed in envelopes, then when a new person enters the study, the next envelope is opened and the sample is assigned to the corresponding treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Comparing the effectiveness of establishing continuous positive airway pressure through RAM cannula with nasal mask and nasal prong in newborns admitted to neonatal intensive care unit.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:Babies treated with RAM cannula: Babies in this group are supported by a Neotech RAM cannula of the right size according to the manufacturer's instructions, which is properly fixed on the baby's face and is directly connected to the continuous positive airway pressure circuit. Intervention 2: Control group1: Control group: group supported by nasal prongs: infants in this group are supported by Medin nasal prongs with the appropriate size (according to the manufacturer's recommendations) whose prongs are directly attached using Mini flow and rubber bands that are placed on Medin caps with the appropriate size ( according to the manufacturer's recommendations) are connected to the continuous positive pressure circuit of the airways. Intervention 3: Control group2: Nasal mask supported group (second control group): Babies in this group are supported by Medin model nasal mask with the right size, which is connected to the positive pressure circuit using Mini flow and rubber bands on caps with Medin model with the right size (according to the manufacturer's recommendations). Continuous airways are connected and placed.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zeinab Keshavarzian kelishadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 1. Andisheh A1 CPLX, Shafagh Blvd. Esfahan, Iran</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8456119488</zip>
        <telephone>+98 31 3782 0696</telephone>
        <email>z.keshavarzian1992@gmail.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zeinab Keshavarzian Kelishadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 1. Andisheh A1 CPLX, Shafagh Blvd. Esfahan, Iran</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8456119488</zip>
        <telephone>+98 31 3782 0696</telephone>
        <email>z.keshavarzian1992@gmail.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Babies born with a gestational age of 28-34 weeks
Need to connect to continuous positive airway pressure within the first hour of birth
Apgar more than 6 in the fifth minute
Absence of congenital malformation including nasal obstruction or severe upper airway malformation such as Cowan's atresia, cleft lip and palate, congenital diaphragmatic hernia, cardiac anomalies, tracheoesophageal fistula, Pierre-Robin sequence
Absence of wounds or lesions in the nose and upper lip of the baby
Consent of parents of infants to participate in the study
Having at least a bachelor's degree in nursing
At least one year of clinical experience in neonatal intensive care unit</inclusion_criteria>
      <agemin>196 days</agemin>
      <agemax>238 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Death of a baby
Changing the type of respiratory interface
The baby needs endotracheal intubation
The baby needs resuscitation
Parents' unwillingness to continue the treatment process
Referral of the baby to another hospital during the study
Unwillingness of nurses to continue cooperation
Failure to answer questionnaire questions
Changing the place of clinical activity to another department during the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:Babies treated with RAM cannula: Babies in this group are supported by a Neotech RAM cannula of the right size according to the manufacturer's instructions, which is properly fixed on the baby's face and is directly connected to the continuous positive airway pressure circuit.</i_keyword>
      <i_keyword>Control group1: Control group: group supported by nasal prongs: infants in this group are supported by Medin nasal prongs with the appropriate size (according to the manufacturer's recommendations) whose prongs are directly attached using Mini flow and rubber bands that are placed on Medin caps with the appropriate size ( according to the manufacturer's recommendations) are connected to the continuous positive pressure circuit of the airways.</i_keyword>
      <i_keyword>Control group2: Nasal mask supported group (second control group): Babies in this group are supported by Medin model nasal mask with the right size, which is connected to the positive pressure circuit using Mini flow and rubber bands on caps with Medin model with the right size (according to the manufacturer's recommendations). Continuous airways are connected and placed</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Mean success and failure of continuous positive airway pressure. Timepoint: From the start of the intervention for 72 hours. Method of measurement: A researcher-made checklist for the effectiveness of continuous positive airway pressure.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Frequency distribution of nose injuries. Timepoint: During the study. Method of measurement: Nose injury checklist.</sec_outcome>
      <sec_outcome>Average satisfaction score of nurses. Timepoint: Immediately after the intervention. Method of measurement: A researcher-made questionnaire of nurses' views on the ease of doing work with three types of respiratory interfaces.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-09-03</approval_date>
        <contact_name>Isfahan University of Medical Sciences</contact_name>
        <contact_address>Esfahan University of Medical Sciences, Hezar Jarib St., Isfahan, Isfahan, Iran Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
